Home » News » Drug Sponsors » Regeneron, BioMed Realty break ground on New York R&D facility

Regeneron, BioMed Realty break ground on New York R&D facility

Monday, October 28, 2013

Regeneron Pharmaceuticals and BioMed Realty Trust have broken ground on a new 300,000-square-foot build-to-suit research facility for Regeneron at BioMed Realty’s The Landmark at Eastview campus in Westchester County, New York.

Upon completion, Regeneron will lease and fully occupy for a 15-year term the to-be-built laboratory and office space adjacent to its other Landmark facilities. BioMed Realty estimates the new buildings will be occupied by Regeneron in late 2015.

Related Posts